Viron Therapeutics, Inc. – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 0 PAGES: 30

More Info
									   Viron Therapeutics, Inc. – Product Pipeline Review –
                         Q1 2011
                                                                                          Reference Code: GMDHC1132CDB

                                                                                                Publication Date: APR 2011




Viron Therapeutics, Inc. – Product Pipeline Review – Q1 2011                                GMDHC1132CDB / Published APR 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Viron Therapeutics, Inc. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        4
List of Figures                                                                                                       4
Viron Therapeutics, Inc. Snapshot                                                                                     5
    Viron Therapeutics, Inc. Overview                                                                                 5
    Key Information                                                                                                   5
    Key Facts                                                                                                         5
Viron Therapeutics, Inc. – Research and Development Overview                                                          6
    Key Therapeutic Areas                                                                                             6
Viron Therapeutics, Inc. – Pipeline Review                                                                            8
    Pipeline Products by Stage of Development                                                                         8
    Pipeline Products – Monotherapy                                                                                   9
Viron Therapeutics, Inc. – Pipeline Products Glance                                                                  10
    Viron Therapeutics, Inc. Clinical Stage Pipeline Products                                                        10
         Phase II Products/Combination Treatment Modalities                                                          10
    Viron Therapeutics, Inc.–Early Stage Pipeline Products                                                           11
         Pre-Clinical Products/Combination Treatment Modalities                                                      11
Viron Therapeutics, Inc. – Drug Profiles                                                                             12
    VT-111                                                                                                           12
         Product Description                                                                                         12
         Mechanism of Action                                                                                         12
         R&D Progress                                                                                                12
    VT-111                                                                                                           13
         Product Description                                                                                         13
         Mechanism of Action                                                                                         13
         R&D Progress                                                                                                13
    VT-214                                                                                                           14
         Product Description                                                                                         14
         Mechanism of Action                                                                                         14
         R&D Progress                                                                                                14
    VT-310                                                                                                           15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    VT-346                                                                                                           16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    VT-362                                                                                                           17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    VT-384                                                                                                           18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18




Viron Therapeutics, Inc. – Product Pipeline Review – Q1 2011                              GMDHC1132CDB / Published APR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Viron Therapeutics, Inc. – Product Pipeline Review



Viron Therapeutics, Inc. – Pipeline Analysis                                                                         19
    Viron Therapeutics, Inc. – Pipeline Products by Therapeutic Class                                                19
    Viron Therapeutics, Inc. - Pipeline Products By Target                                                           21
    Viron Therapeutics, Inc. – Pipeline Products by Route of Administration                                          22
    Viron Therapeutics, Inc. – Pipeline Products by Molecule Type                                                    23
Viron Therapeutics, Inc. – Recent Pipeline Updates                                                                   24
Viron Therapeutics, Inc. – Locations And Subsidiaries                                                                25
    Head Office                                                                                                      25
Financial Deals Landscape                                                                                            26
    Viron Therapeutics, Inc., Deals Summary, 2004 to 2011                                                            26
    Viron Therapeutics, Inc. Detailed Deal Summary                                                                   27
         Venture Financing                                                                                           27
         Viron Therapeutics Secures $20 Million In Series A Financing                                                27
Appendix                                                                                                             29
    Methodology                                                                                                      29
         Coverage                                                                                                    29
         Secondary Research                                                                                          29
         Primary Research                                                                                            29
         Expert Panel Validation                                                                                  
								
To top